India's healthcare crisis deepens as chronic diseases surge despite economic growth
India's healthcare crisis deepens as chronic diseases surge despite economic growth
India's healthcare crisis deepens as chronic diseases surge despite economic growth
India's health economy is growing rapidly, yet the population's health is not keeping pace. Experts gathered at the Ahmedabad Dialogue 2024 to explore why chronic diseases are rising and how the system could shift from treatment to prevention. The event, hosted by Ahmedabad University's Bagchi School of Public Health, brought together policymakers and researchers to address gaps in the current approach.
The dialogue highlighted a key issue: India's healthcare system still prioritises treating illness over preventing it. Chronic and lifestyle-related diseases are now appearing earlier in life, particularly in disadvantaged communities. These groups face greater economic strain and poorer health outcomes, making equity a critical factor in long-term sustainability.
Participants discussed how technology could enable earlier interventions and better prevention. However, since the event, no new laws or structural reforms—such as changes to payment models or subsidies—have been introduced. Existing programmes, like the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke, continue without major updates as of February 2026.
Ahmedabad University, a private research institution known for its interdisciplinary focus, organised the discussions. Insights from the panel and roundtables will be shared to inform future policy decisions. The goal remains clear: turning India's expanding health capacity into tangible improvements in public health.
The Ahmedabad Dialogue underscored the need for systemic change to reduce chronic disease rates. Without structural reforms, the gap between healthcare spending and population health may widen. The findings aim to guide policymakers toward more effective prevention strategies in the years ahead.
Taiwan battles early flu surge and rising dengue fever cases ahead of holidays
A perfect storm of flu and dengue hits Taiwan just as holidays approach. Could crowded gatherings worsen the outbreak?
Johnson & Johnson defies market slump with 15% stock surge in 2024
A pharma giant thrives where others falter. How J&J's billion-dollar drugs and smart spin-offs outperform a volatile market.
India warns Pakistan over Sir Creek with military show of strength
A sacred weapon ritual and a bold warning: India flexes its military muscle as tensions rise over the unresolved Sir Creek border. What happens next?
Guernsey's life-saving cholesterol screening earns national award nomination
A tiny island's bold health initiative is saving lives—and catching national attention. Could this cholesterol screening model reshape care across the UK?